We spoke to new Sterling Energy CEO Tony Hawkins about the latest changes happening at the company. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,212.20
Bid: 1,212.20
Ask: 1,212.40
Change: -0.80 (-0.07%)
Spread: 0.20 (0.02%)
Open: 1,215.00
High: 1,220.40
Low: 1,204.80
Yest. Close: 1,213.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

RBS Posts Loss After Citizens Writedown But Hails Underlying Progress

26 Feb 15 07:46

Howard Davies set to be confirmed as RBS chairman -sources

By Alexander Smith and Lauren Tara LaCapra LONDON/NEW YORK, Feb 25 (Reuters) - Royal Bank of Scotland Group PLC is set to confirm the appointment of Howard Davies as its new chairman on Thursday, a source familiar with the matter told Reuters. Davies, a former top UK regulator who ser

25 Feb 15 21:52

GSK set to complete $20 bln Novartis asset swap next week

LONDON, Feb 25 (Reuters) - GlaxoSmithKline said on Wednesday it expected to conclude a $20 billion-plus three-part asset swap with Novartis in the week commencing March 2, following progress in obtaining clearances for the deal. GSK is forming a consumer health joint venture with Novartis,

25 Feb 15 16:42

GSK will complete Novartis three-way deal by end of next week

UK drugs giant GlaxoSmithKline says it has made "good progress" on regulatory and legal issues towards completion of its deal with Swiss rival Novartis. GSK said it expected to complete the deal next week, just under a year after it was first announced, with the two pharmaceuticals groups trading ov

25 Feb 15 16:33

UPDATE 1-Medicago wins contract to develop Ebola treatments

(Adds details on background, competition) Feb 24 (Reuters) - Canadian drugmaker Medicago said it received a contract from a U.S. federal agency to develop three different potential treatments for Ebola. The company said on Tuesday it would make the antibodies in its Quebec facility fo

24 Feb 15 15:47

UPDATE 1-Novartis AG wins approval to buy GSK cancer drugs, with conditions

(Adds Canada approving deal, details on divestitures, background on three-way deal) WASHINGTON, Feb 23 (Reuters) - Novartis AG has won U.S. antitrust approval to buy GlaxoSmithKline's oncology drugs, with conditions, the U.S. Federal Trade Commission said on Monday. Canada's competit

23 Feb 15 17:34

Canada competition bureau approves GlaxoSmithKline/Novartis deal

OTTAWA, Feb 23 (Reuters) - Canada's Competition Bureau on Monday approved a deal between GlaxoSmithKline PLC and Novartis AG, noting in a statement that U.S. authorities had already said the transaction could go ahead. The companies agreed last April to the transaction that includes GSK buy

23 Feb 15 17:11

CORRECTED-Novartis AG wins approval to buy GSK cancer drugs with conditions

(Corrects name of inhibitor in paragraph two to MEK from MIK) WASHINGTON, Feb 23 (Reuters) - Novartis AG has won U.S. antitrust approval to buy GlaxoSmithKline's oncology drugs with conditions, the Federal Trade Commission said on Monday. To win approval for the $16 billion deal, Nov

23 Feb 15 17:05

Novartis AG wins approval to buy GSK cancer drugs with conditions

WASHINGTON, Feb 23 (Reuters) - Novartis AG has won U.S. antitrust approval to buy GlaxoSmithKline's oncology drugs with conditions, the Federal Trade Commission said on Monday. To win approval for the $16 billion deal, Novartis agreed to divest assets related to its BRAF and MIK inhibitor

23 Feb 15 16:29

Australian regulator says will not oppose GSK, Novartis deals

SYDNEY, Feb 20 (Reuters) - Australia's competition regulator said on Friday it will not oppose a three part deal between Novartis and GlaxoSmithKline to trade more than $20 billion worth of assets, following approval from EU regulators. The companies agreed last April to the transaction tha

19 Feb 15 23:48

FTSE 100 movers: Centrica drops, oil and gas stocks lower

With oil and gas prices plummeting, Centrica took dramatic action by slashing its dividend and future payout policy, warning that earnings for next year will be lower than expected too. Shares in the British Gas owner dropped sharply the company cut its dividend 21% to 19.2p, which will be a "major

19 Feb 15 14:14

Taihua Total Sales Up For 2014 As Price Increase Offsets Lower Harvest

19 Feb 15 11:41

UK WINNERS & LOSERS: Centrica Shares Tumble On Dividend Cut, Warning

19 Feb 15 11:26

UK Dividends Calendar - Week Ahead

19 Feb 15 06:24

UK Dividends Calendar - Week Ahead

18 Feb 15 16:22

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.